Clergy for a New Drug Policy

Clergy for a New Drug Policy
Name	Clergy for a New Drug Policy
Formation	2003
Founders	Rev. Paul K. Robeson Jr.; Rev. Dr. James Gilligan
Type	Religious advocacy group
Headquarters	New York City
Region served	United States

Clergy for a New Drug Policy is an interfaith network of religious leaders, ministers, rabbis, imams, and clergy advocating for drug policy reform, harm reduction, and alternatives to incarceration. Founded in the early 2000s, the group has engaged with policymakers, nonprofit organizations, and community leaders to shift public debate on substance use, criminal justice, and public health. Its positions intersect with debates involving civil rights, public safety, and medical ethics across municipal, state, and federal arenas.

History and Formation

Clergy for a New Drug Policy was established amid debates following the 1990s sentencing reforms and the 2000s drug policy initiatives, drawing influence from figures associated with the civil rights movement and criminal justice reform. Early founders and supporters have included clergy who previously engaged with campaigns linked to NAACP, American Civil Liberties Union, and local coalitions in New York City, Los Angeles, and Chicago. The group’s emergence paralleled shifts in public opinion reflected in polling by organizations such as Pew Research Center and legislative changes like ballot measures in California, Colorado, and Washington (state). Its formation drew on theological and pastoral networks connected to denominations including the United Methodist Church, United Church of Christ, Evangelical Lutheran Church in America, and Jewish movements represented by the Union for Reform Judaism.

Mission and Goals

The organization articulates goals framed by religious ethics and public health evidence, advocating alternatives to punitive drug laws similar to reforms enacted by legislatures in Massachusetts, Oregon, and Vermont. It promotes policies that intersect with initiatives led by groups such as Drug Policy Alliance, Harm Reduction Coalition, and public health agencies like the Centers for Disease Control and Prevention and National Institutes of Health. The stated aims often cite dialogues with elected officials from the United States Congress, state governors, and municipal leaders in cities like Philadelphia and San Francisco to advance restorative justice, diversion programs, and access to treatment modeled on projects in Portugal and Switzerland.

Activities and Advocacy

Clergy for a New Drug Policy engages in public testimony, amicus briefs, pastoral care programs, and grassroots mobilization tied to campaigns by advocacy organizations including ACLU, Amnesty International USA, and faith-based relief agencies such as Catholic Charities USA. Activities include participation in hearings before state legislatures and federal committees, collaboration with researchers at institutions like Columbia University, Johns Hopkins University, and Harvard University to present evidence on overdose prevention, as well as organizing interfaith vigils and educational conferences alongside groups like The Sentencing Project and Vera Institute of Justice. The network has supported harm reduction initiatives including syringe access programs, naloxone distribution efforts coordinated with American Red Cross chapters, and supervised consumption site debates influenced by models in Vancouver and Lisbon.

Organizational Structure and Membership

The group is structured as a loose coalition of clergy and faith communities, with regional coordinators and advisory councils that include theologians, pastoral counselors, and legal experts connected to institutions such as Yale University, Princeton Theological Seminary, and Union Theological Seminary. Membership encompasses leaders from denominations like the Presbyterian Church (USA), Roman Catholic Church, and African Methodist Episcopal Church, as well as representatives from Muslim, Jewish, Buddhist, and indigenous spiritual traditions. Advisory relationships have linked the organization with policy think tanks including Brookings Institution, RAND Corporation, and community health networks in metropolitan areas like Detroit and Baltimore.

Public Impact and Criticism

Clergy for a New Drug Policy has been credited by commentators and policymakers with helping reframe drug policy debates toward public health, influencing ballot campaigns in states such as California and Colorado, and contributing testimony in reform efforts in New York State and Massachusetts. Supporters cite collaborations with leaders like Bishop Desmond Tutu-inspired moral arguments and public endorsements from faith figures associated with Sojourners and other religious advocacy organizations. Critics, including some denominational leaders and conservative advocacy groups tied to organizations like Faith and Freedom Coalition and certain factions within Republican Party, argue the group’s positions risk undermining law enforcement priorities and community standards. Scholarly critiques published in journals affiliated with Oxford University Press and Cambridge University Press have debated the effectiveness of faith-led reform versus secular policy advocacy.

Notable Campaigns and Partnerships

Notable campaigns include coalition work supporting decriminalization initiatives modeled after Portugal’s reforms, partnerships with public health campaigns coordinated with World Health Organization and UNODC frameworks, and local programs in partnership with harm reduction providers like Harm Reduction Coalition and municipal health departments in Seattle, Portland, Oregon, and New Orleans. The organization has also partnered with criminal justice reform groups such as The Marshall Project and Equal Justice Initiative to promote diversion courts, reentry services, and faith-based treatment alternatives piloted in collaboration with university research teams at University of California, San Francisco and Yale School of Medicine.

Category:Drug policy organizations Category:Religious organizations based in the United States